These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8610652)

  • 1. Episcleral plaque thermoradiotherapy of posterior uveal melanomas.
    Petrovich Z; Pike M; Astrahan MA; Luxton G; Murphree AL; Liggett PE
    Am J Clin Oncol; 1996 Apr; 19(2):207-11. PubMed ID: 8610652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episcleral plaque thermoradiotherapy in patients with choroidal melanoma.
    Petrovich Z; Astrahan MA; Luxton G; Green R; Langholz B; Liggett P
    Int J Radiat Oncol Biol Phys; 1992; 23(3):599-603. PubMed ID: 1612961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
    PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: a prospective randomized trial.
    Girvigian MR; Astrahan MA; Lim JI; Murphree AL; Tsao-Wei D; Petrovich Z
    Brachytherapy; 2003; 2(4):229-39. PubMed ID: 15062131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave thermoradiotherapy for uveal melanoma: results of a 10-year study.
    Finger PT
    Ophthalmology; 1997 Nov; 104(11):1794-803. PubMed ID: 9373109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
    Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
    Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
    Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.